Skip to main content
Signal8

MindMaze Therapeutics Holding SA (RLFTY)

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

MindMaze Therapeutics Holding S.A. logo

MindMaze Therapeutics Holding S.A.

CLOSED
Mkt Cap-
EV-
Float37.2M
O/S-
VOL3K sh
$ Vol$445
RVOL1.00×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution

No press releases found for RLFTY.